Description
Erlonat™ is a quality assured generic of Tarceva® used as a monotherapy to treat advanced non-small cell lung cancer in patients who have certain types of abnormal epidermal growth factor (EGFR) gene-activating mutations. It’s also used to treat advanced pancreatic cancer in combination with chemotherapy. It’s produced in a US FDA approved factory in India.
Bottle Size : 30 Tablets
Active Ingredients : Erlotinib 100
Produced by Natco Pharma Ltd®